Novartis Animal Health U.S., Inc., adds the new VICRYL-Plus Antibacterial (polyglactin 910) Suture to its line of sutures. The company says it is the first device ever to inhibit bacterial colonization on the suture line.
Novartis Animal Health U.S., Inc., adds the new VICRYL-Plus Antibacterial (polyglactin 910) Suture to its line of sutures.The company says it is the first device ever to inhibit bacterial colonization on the suture line.VICRYL Plus suture is the first and only suture designed with an antibacterial agent, IRGACARE MP* (Triclosan), the company says. It is known to be effective against several species of staphylococcus organisms, which are common around the surgical incision site.This marks the first time an antibacterial-coated suture for wound closure has been introduced in veterinary medicine, says Dr. Jim Blacka, professional services veterinarian for Novartis animal Health, U.S. It is truly an innovative surgical introduction for our profession. This inhibits bacterial colonization of the suture by pathogens that may be at the origin of surgical site infections.Because the suture is absorbable, it should not be used where extended approximation of tissue under stress is required, the company says. The suture should not be used in patients with known allergic reactions to IRGACARE MP* (Triclosan).
For fastest response call (336) 387-1000 or visit the Web site at www.petwellness.com.